Rybińska, M. et al. 2026. Tirzepatide vs. Cagrilintide/Semaglutide: A New Frontier in Pharmacological Management of Obesity. Journal of Education, Health and Sport. 95, (Sep. 2026), 73651. DOI:https://doi.org/10.12775/JEHS.2026.95.73651.